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ABSTRACT 
Chronic hypoxia in pulmonary diseases is known to have a severe negative impact on heart function, including right 
heart hypertrophy, increased workload on the heart and arrhythmia. Yet, the direct effect of the chronic hypoxic 
environment on the cardiovascular system is still not fully understood. Usual pre-clinical analytic methods analysing 
this effect are limited to ex vivo histology or highly invasive approaches such as right heart catheterisation, which 
inevitably interfere with cardiac tissue. In this work, we propose volumetric optoacoustic tomography as a method 
for assessing heart function in response to chronic hypoxia non-invasively. Hypoxic and normoxic murine hearts 
were imaged in vivo at high temporal (100 Hz) and spatial resolution (200 µm). Analysis of the murine models on a 
beat-to-beat scale enabled identifying and characterizing arrhythmic events in hypoxic models. In addition, blood 
flow was tracked using indocyanide green (ICG) contrast agent, which revealed a clear difference in the pulmonary 
transit time (PTT) between the hypoxic and normoxic models. Validation for presence of hypoxia in the lungs was 
carried out by α-smooth muscle actin staining for muscularization of the pulmonary vasculature. We expect that the 
novel capabilities offered by volumetric optoacoustic tomography for analysing impaired heart function under 
hypoxic conditions in pre-clinical models will provide important insights into early diagnosis and treatment methods 
for pulmonary diseases. 
1. INTRODUCTION 
Pulmonary disease is one of the leading causes of mortality worldwide, following closely after cardiovascular 
disease which continuously holds highest mortality rates [1]. Chronic hypoxic conditions in the lung affect normal 
physiological processes, including heart function. Chronic hypoxia, which may be caused by chronic obstructive 
pulmonary disease (COPD) and high altitudes for non-native dwellers may have severe outcomes such as pulmonary 
vasoconstriction caused by the muscularization of otherwise non-muscular arteries contributing to pulmonary heart 
disease (PHD) [2-4].  
Current clinical methods of detection include Ultrasound (US) and Magnetic Resonance Imaging (MRI) for 
evaluation of right ventricular (RV) hypertrophy and right atrial (RA) dilation; Electrocardiogram (ECG) for RV 
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hypertrophy and arrhythmia; and RV catheterization for pressure sensing [5-6]. In pre-clinical studies, methods of 
assessing heart function in PHD are limited to histopathological ex vivo analyses or highly interfere with the 
integrity of the heart tissue. To our knowledge, non or minimally invasive imaging and assessment of pre-clinical 
models of hypoxia has not yet been established.  
Optoacoustic (OA, photoacoustic) is becoming a powerful tool in pre-clinical imaging and is highly suited to in vivo 
cardiac imaging due its high spatial and temporal resolution, indigenous and exogenous optical contrast and a deeper 
visualization of the heart in a non-invasive manner. Recent developments in OA imaging has allowed for 3D 
volumetric and real-time (beat to beat scale) imaging of the mouse heart, overcoming the limitations of 2D imaging 
[7]. The non - invasive nature of OA imaging ensures an intact heart throughout imaging and analysis, thus offering 
a more accurate overview on heart function. In this work, we demonstrate a method in which in vivo heart function 
is analyzed non-invasively in chronic hypoxic murine models with an aim to deepen our understanding of the effects 
on the circulatory system in response to an impaired pulmonary system.   
2. METHODS 
2.1 Chronic Hypoxic Model and Handling:  
All animal experiments were approved and conducted under the local regulations (Government of Upper Bavaria 
Munich and Helmholtz Centre Munich under animal protocol reference number 55.2-1-2532-50-12). Mice 
(129S/Sv/C57BL6 mixed background) were divided into two groups, namely hypoxic (10% oxygen for 21 days, 
n=5) and normoxic/control (n=5) (Fig 1A). Induction of hypoxia as a disease model of chronic hypoxic conditions 
was based on a previously described method [8]. Mice were anesthetised with 2% isoflurane – oxygen medical mix 
(~0.81 l/min gas flow) for in vivo heart imaging and placed on top of the OA imaging probe filled with a solid clear 
agar matrix (3w/v% conc.). 100 nmol of FDA-approved indocyanine green (ICG, Profiplus Bvba, Kortessem, 
Belgium) diluted in 50 µl saline solution was injected intravenously after the beginning of the image acquisition 
procedure. 
2.2 OA Imaging of Heart Function:  
High-frame-rate images of the beating mouse heart were acquired with a volumetric optoacoustic tomography (vOT) 
system specifically designed for high quality pre-clinical cardiac imaging (Fig.1 B) [7][9] A detailed description of 
the vOT imaging set up has been previously described in detail [7]. In short it is composed of a spherical array 
transducer (Imasonic Sas, Voray, France) (Fig. 1B), where the heart was illuminated (800nm at sampling frequency 
100Hz) with a fast-tuning pulsed laser (Innolas Laser GmbH, Krailling, Germany) guided via a fibre bundle (Ceram 
Optec GmbH, Bonn, Germany), where OA signals were sampled by the data acquisition system (Falkenstein 
Microsysteme GmbH, Taufkirchen, Germany). The wavelength corresponds to the absorbance peak of ICG. OA 
data was acquired for each ICG injection and 3D images were reconstructed in a volume of 12x12x12 mm3 
(120x120x120 voxels) using the back-projection method (Fig. 1 C) [10].  
2.3 PTT & heart beat analysis: 
The method for extracting the pulmonary transit time (PTT ) values from the heart is described in detail in previous 
work [7]. In short, the PTT was measured as the difference between the maximum signal peaks between the right 
and left ventricles, corresponding to the time of appearance of the ICG bolus (Fig. 2A). The PTT was measured for 
each ICG injection for hypoxic and normoxic models and heart waveforms from different structures of the heart 
including the right atrium (RA), right ventricle (RV), left ventricle (LV) and aorta were extracted from images (Fig 
2A). Abnormal beating events were identified when a single heartbeat length was significantly longer than other 
heartbeats rendering a normal periodic rhythm. 
2.4 Lung Remodelling:  
Lungs were isolated and stained with alpha-smooth actin for the presence of small muscularized vessels for 
validation that chronic hypoxic conditions were present in the murine models. 
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The blood flow within the pulmonary circuit of the mice was tracked with ICG injection. Since the absorption peak 
of ICG is approximately at 800nm, the use of this wavelength was employed in order to visualise the dye clearly. 
The blood was tracked within one heartbeat from entry into the right heart and re-entry into the left heart and aorta, 
after completion of the pulmonary circuit (Fig. 2A). The OA signal intensity was plotted across 12 seconds (1200 
frames) of a voxel within the RV, LV and aorta. The curves were plotted before, during and after ICG injection in 
order to track the change in OA signal intensity, correlating to the blood flow, at different locations in the heart (Fig. 
2A). The PTT was measured as the time it takes the ICG bolus (or blood) to enter the right heart, travel through the 
lungs and return to the left heart. The entry times of the ICG can be visualised as the maximum OA signal intensities 
within the extracted curves. 
3.2 PTT analysis and irregular heartbeat detection: 
The PTT was measured for all hypoxic and normoxic models as described in the methods (Fig 2B). A t-test was 
carried out in order to analyse the difference between the PTT values of the models. The PTT values measured from 
the hypoxic models (mean 1.91s) were significantly longer than the normoxic models (mean 1.43s; P < 0.0026). 
The PTT suggest the time taken for the heart to deliver blood through the pulmonary circuit is significantly longer in 
hypoxic models.  
After image reconstruction of 2000 frames with vOT, irregular heart beating was clearly identified within the 
hypoxic models, whereas only regular beating was visualised in normoxic models. Waveforms of the OA signal 
intensity over time presented clear abnormalities; where heartbeats of normal length were interrupted with larger 
beating periods (Fig. 3A). The disturbed heart beats take a significantly longer time to complete one heartbeat (P < 
0.0001) (Fig 3B). The trends in the beating mouse heart were identified due to the 100Hz temporal resolution of 
vOT.  
3.3 Lung remodelling: 
Increased muscuralization of vessels was present in lungs under hypoxic conditions. A clear difference was found 
between the hypoxic and normoxic models (p < 0.01), where the number of muscularized vessels was greater in 
hypoxic lungs compared to normoxic lungs (Fig. 4). The histopathological results were used as validation for the 
presence of hypoxia in the murine models.  
3. DISCUSSION 
We have studied the potential of vOT for assessing in vivo heart function in murine models in response to chronic 
hypoxic conditions and have shown that the heart function of hypoxic models was significantly impaired in response 
to the reduced oxygen intake by analysing the pulmonary transit time and heartbeat irregularities. So far, pre-clinical 
assessment of PHD has been often limited to ex vivo or highly invasive procedures that interfere with the integrity of 
the heart tissue, thus an overall accurate perception of heart function in living organisms remains inaccessible.  
The PTT in hypoxic models was considerably longer than in normoxic models, indicating deteriorated heart function 
in response to hypoxic conditions. This parameter has previously been shown to serve as an accurate indicator of 
heart performance under pathophysiological conditions in the murine heart [11]. The significantly longer PTT in the 
hypoxic models strongly suggests an impaired pulmonary circuit within hypoxic mice. The narrowed pulmonary 
vasculature, a result of chronic hypoxic conditions, likely increases resistance of blood flow from the heart, causing 
it to work harder while also weakening the cardiac muscle. Histopathological studies of vessel muscularization in 
the lungs is generally considered the gold standard for evaluation of presence of hypoxia in the lungs. However, 
analysis of vessel muscularization is limited to ex vivo studies, while vOT can offer an alternative method of 
analysis of in vivo heart function.  
Arrhythmic events resulting from hypoxic conditions (including COPD) are well documented in humans [12]. 
Irregular heart beating within the hypoxic mice models could be detected with vOT. The waveforms extracted in 
vivo from the heart using vOT followed similar outlines of pressure waveforms that are usually extracted by 
catheterisation [13]. Such waveforms easily detect changes in the heart beat rhythm corresponding to abnormalities 
in the cardiac cycle.  
3. RESULTS 
3.1 Real-time tracking of blood flow: 
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Figure 2: PTT (A) Blood flow tracking with ICG through a single heartbeat with PTT and waveform extraction 
(PTT; pulmonary transit time, RV; right ventricle, LV; left ventricle). (B) A box plot representing the acquired 
PTT values measured in normoxic and hypoxic mice, where a significant difference (p < 0.0026) was measured 
(Nx; normoxic, Hx; hypoxic  
Figure 3: Abnormal beat characterisation (A) Plots of heart beat cycles in 2 hypoxic, where normal beats are 
highlighted in blue and irregular beats are highlighted in red (H; Hypoxic mouse (B) A box plot representing 
differences in time of normal beating cycles (mean 189.1ms per beat) and abnormal beating cycles (mean 
333.3ms per beat), where significant difference was measured (P < 0.00001) (NB; normal beating, AB; abnormal 
beating). 
Proc. of SPIE Vol. 10878  108782B-5
Downloaded From: https://www.spiedigitallibrary.org/conference-proceedings-of-spie on 18 Feb 2021














[1] World Health Organisation Chronic respiratory diseases, burden of COPD,“ World Health Organisation, 
[Online]. Available: www.who.int/respiratory/copd/burden/en/index.html 
[2] West, J. B. (2004). The physiologic basis of high-altitude diseases. Annals of Internal Medicine, 141(10), 789-
800. 
[3] Blanco, I., Piccari, L., & Barberà, J. A. (2016). Pulmonary vasculature in COPD: the silent 
component. Respirology, 21(6), 984-994. 
[4] Stenmark, K. R., Fagan, K. A., & Frid, M. G. (2006). Hypoxia-induced pulmonary vascular remodeling: cellular 
and molecular mechanisms. Circulation research, 99(7), 675-691. 
[5] Weitzenblum, E. (2003). Chronic cor pulmonale. Heart, 89(2), 225-230. 
[6] Rosenkranz, S., & Preston, I. R. (2015). Right heart catheterisation: best practice and pitfalls in pulmonary 
hypertension. European Respiratory Review, 24(138), 642-652. 
[7] Deán-Ben, X. L., Ford, S. J., & Razansky, D. (2015). High-frame rate four dimensional optoacoustic tomography 
enables visualization of cardiovascular dynamics and mouse heart perfusion. Scientific reports, 5, 10133. 
[8]  Li, Y., Shi, B., Huang, L., Wang, X., Yu, X., Guo, B., & Ren, W. (2016). Suppression of the expression of 
hypoxia-inducible factor-1α by RNA interference alleviates hypoxia-induced pulmonary hypertension in adult 
rats. International journal of molecular medicine, 38(6), 1786-1794. 
[9] Dean-Ben, X. L., Ozbek, A., & Razansky, D. (2013). Volumetric real-time tracking of peripheral human 
vasculature with GPU-accelerated three-dimensional optoacoustic tomography. IEEE transactions on medical 
imaging, 32(11), 2050-2055. 
[10] Ozbek, A., Deán-Ben, X. L., & Razansky, D. (2013, May). Realtime parallel back-projection algorithm for 
three-dimensional optoacoustic imaging devices. In European Conference on Biomedical Optics (p. 88000I). Optical 
Society of America. 
Figure 4: Lung Remodelling: SMActin staining of murine lungs , where there is significantly more (p<0.01) 
muscularized small vessels in hypoxic lungs compared to normoxic lungs (Nx, normoxic, Hx, hypoxic). 
Proc. of SPIE Vol. 10878  108782B-6
Downloaded From: https://www.spiedigitallibrary.org/conference-proceedings-of-spie on 18 Feb 2021
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
 
 
[11] Lin, H. C. A., Déan-Ben, X. L., Ivankovic, I., Kimm, M. A., Kosanke, K., Haas, H., ... & Razansky, D. (2017). 
Characterization of Cardiac Dynamics in an Acute Myocardial Infarction Model by Four-Dimensional Optoacoustic 
and Magnetic Resonance Imaging. Theranostics, 7(18), 4470. 
[12] Hanrahan, J. P., Grogan, D. R., Baumgartner, R. A., Wilson, A., Cheng, H., Zimetbaum, P. J., & Morganroth, J. 
(2008). Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the 
effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. Medicine, 87(6), 319-
328. 
[13] Kern, M. J., Lim, M. J., & Goldstein, J. A. (Eds.). (2018). Hemodynamic rounds: interpretation of cardiac 





Proc. of SPIE Vol. 10878  108782B-7
Downloaded From: https://www.spiedigitallibrary.org/conference-proceedings-of-spie on 18 Feb 2021
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
